MAUREEN MCCORMICK: Open Payments
NPI 1548623531 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,090 in 37 payments from 10 companies in 2025. Trend: 2023 $616 · 2024 $859 · 2025 $1,090
Food & beverage: $1,090
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $561 |
| GlaxoSmithKline, LLC. | 10 | $234 |
| Amgen Inc. | 4 | $85 |
| Verona Pharma, Inc. | 2 | $51 |
| Eisai Inc. | 2 | $47 |
| Madrigal Pharmaceuticals | 1 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Exelixis Inc. | 1 | $15 |
| Genentech USA, Inc. | 1 | $14 |
Products named: NUCALA, FASENRA, AIRSUPRA, TEZSPIRE, Ohtuvayre, Lenvima, BREZTRI, REZDIFFRA.
Industry payments across OH — which companies pay providers there.
